Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis

Background/Aim: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with multisystemic involvement. Almost 50 % of patients who suffer from systemic lupus erythematosus have lupus nephritis (LN) as well. Mycophenolate mofetil (MMF) or intravenous cyclophosphamide (CYC) are recommended...

Full description

Saved in:
Bibliographic Details
Main Authors: Božić-Majstorović Ljubinka, Popović-Pejičić Snježana, Mrđa Jelena, Mrđa Vladimir, Ovčina Irma
Format: Article
Language:English
Published: Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine 2024-01-01
Series:Scripta Medica
Subjects:
lupus erythematosus, systemic
lupus nephritis
cyclophosphamide
mycophenolic acid
mycophenolate mofetil
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2024/2490-33292406743B.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items